Gossamer Bio

GOSSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$87.015 M

$0.18 -0.22%

Close of 7 Aug 2026

Revenue

$48.5M

#2751 by revenue

Earnings

-$170.4M

Loss-making

Shares outstanding

234,696,281

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#313Fortress BiotechFBIO$88.7M
#314Verrica PharmaceuticalsVRCA$87.3M
#315Gossamer BioGOSS$87.0M
#316MAIA BiotechnologyMAIA$86.3M
#317RallybioRLYB$85.6M

Where these numbers come from

Share counts and financials for Gossamer Bio are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.